What medical conditions is Wegovy (semaglutide) contraindicated in?
Anti-hypertensive angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients
As highlighted in our July 2024 blog, animal research suggests potential, but human safety and effectiveness remain unproven, raising significant legal and ethical concerns
In Summary it led to : A1c Reduction up to 2% Weight loss reaching 29% Reduced Liver fat Drop blood pressure by 14 points decreased inflammatory markers reduced osteoarthritis flare ups To view or add a comment, sign in More Relevant Posts New in Med by Cell Press: In a 24-week, randomized, double-blind, placebo-controlled phase 2 trial in Chinese adults with obesity (BMI 30 kg/m2, no diabetes) once-weekly mazdutide 9 mg produced a mean 12.78% weight loss versus a 1.80% gain with placebo (treatment difference 14.58%
Tandra Chakraborty, a professor of biology who, among other things, researches obesity at Adelphi University in Garden City, New York, said that everyone enjoys a little binge eating now and then, and if its just for a day or two, its usually not a big deal for someone healthy. However, she warned that if it goes on longer, it can really set you back. Binge eating can also become a mental health issue if it affects your daily life
